ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

BLRX BioLineRx Ltd

0.6599
0.0846 (14.71%)
26 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
BioLineRx Ltd BLRX NASDAQ Certificado de Depósito
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.0846 14.71% 0.6599 17:40:50
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.5614 0.5528 0.6216 0.6116 0.5753
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
17/4/202406:00PRNUSBioLineRx Announces Poster Presentation on Apheresis Center..
04/3/202406:47EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/2/202406:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/2/202406:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/1/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
29/12/202315:20EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/12/202315:15EDGAR2Form F-3 - Registration statement by foreign private issuers
21/12/202306:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/12/202306:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/11/202306:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/11/202305:25IHMARKETNEWSMonday’s Wall Street Highlights: GM, Microsoft, Citigroup,..
01/11/202306:43PRNCABioLineRx a conclu un accord de licence exclusive pour le..
31/10/202308:00PRNCABioLineRx entered Exclusive License Agreement to..
26/10/202313:18EDGAR2Form SC 13D - General statement of acquisition of beneficial..
18/10/202316:07APSNew Collaboration Could Revolutionize Treatment of Chronic..
12/10/202306:14EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/9/202306:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/9/202306:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/9/202306:00PRNUSBioLineRx Announces FDA Approval of APHEXDA™ (motixafortide)..
30/8/202306:16IHMARKETNEWSWednesday’s Wall Street Highlights: Ambarella, Alphabet,..
30/8/202306:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/8/202305:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/8/202316:25EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/7/202306:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

Su Consulta Reciente

Delayed Upgrade Clock